Revenue
256 million USD
2010-06-30 · USD
Exact inputs and evidence
- Revenue: 255574000 USD Source
Fundies. English
VALEANT PHARMACEUTICALS INTERNATIONAL
EDGAR90 filing records in this dataset, filed from 1994-11-14 to 2010-08-03. Reported financial figures are available; chart coverage varies by period.
Latest quarter
Operating margin
28.24%
2010-06-30 · %
Operating cash flow
59.9 million USD
2010-06-30 · USD
Free cash flow
55.3 million USD
2010-06-30 · USD
- Cash and cash equivalents
- 75.4 million USD Source
Exact value
75383000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2010-08-03.
Financial data available through: 1997-12-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 4 of 11 periods available· newest 1997-12-31
- Operating cash flow: 4 of 11 periods available· newest 1997-12-31
- Capital expenditure: 4 of 11 periods available· newest 1997-12-31
- Total assets: 4 of 11 periods available· newest 1997-12-31
- liabilities: No compatible figures in this window
- Current assets: 4 of 11 periods available· newest 1997-12-31
- Current liabilities: 4 of 11 periods available· newest 1997-12-31
- Cash and cash equivalents: 4 of 11 periods available· newest 1997-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+31.1%Prior period
USD 86.93 million
–
Current period
USD 113.92 million
–
Exact inputs and evidence
113924000 − 86928000 = 26996000 USD
86928000 USD · 1996-01-01 – 1996-12-31
Inspect prior input Prior source113924000 USD · 1997-01-01 – 1997-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 34.86 millionPrior period
−USD 25.55 million
–
Current period
USD 9.32 million
–
Exact inputs and evidence
9315000 − -25548000 = 34863000 USD
-25548000 USD · 1996-01-01 – 1996-12-31
Inspect prior input Prior source9315000 USD · 1997-01-01 – 1997-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+283%Prior period
USD 26.22 million
–
Current period
USD 100.4 million
–
Exact inputs and evidence
100397000 − 26216000 = 74181000 USD
26216000 USD · 1996-01-01 – 1996-12-31
Inspect prior input Prior source100397000 USD · 1997-01-01 – 1997-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 1994 1994-01-01 – 1994-12-31 | −USD 183.58 million Exact valueExact value: -183581000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 42.56 million Exact valueExact value: 42557000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 20.21 million Exact valueExact value: 20205000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 22.35 million Calculation and evidence42557000 − 20205000 USD Exact free cash flow: 22352000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 1995 1995-01-01 – 1995-12-31 | USD 67.34 million Exact valueExact value: 67337000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 79.33 million Exact valueExact value: 79326000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 49.69 million Exact valueExact value: 49685000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 29.64 million Calculation and evidence79326000 − 49685000 USD Exact free cash flow: 29641000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 1996 1996-01-01 – 1996-12-31 | USD 86.93 million Exact valueExact value: 86928000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.55 million Exact valueExact value: -25548000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 26.22 million Exact valueExact value: 26216000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 51.76 million Calculation and evidence-25548000 − 26216000 USD Exact free cash flow: -51764000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 1997 1997-01-01 – 1997-12-31 | USD 113.92 million Exact valueExact value: 113924000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 9.32 million Exact valueExact value: 9315000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 100.4 million Exact valueExact value: 100397000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 91.08 million Calculation and evidence9315000 − 100397000 USD Exact free cash flow: -91082000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
90 filings · 160 latest values · 160 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000930184, 930184, edgar:930184
Also known as ICN MERGER CORP, ICN PHARMACEUTICALS INC